Selective inhibition of NF-kB signaling by natural compounds, nutraceuticals, and chemical agents has been shown to suppress the proliferation of cancer cells and has emerged as a potential molecular target for cancer treatment [63,99,100,101]. Here, NFKB1 is linked to cancer.